Aiping Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aiping Qin has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
Rongyan Qin
Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
10 shared publicationsQiuyan Huang
Key Laboratory of Metabolic Diseases of Baise, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
9 shared publicationsJiaxu Li
Reproductive Medicine Center, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, China
8 shared publicationsQianwen Hu
Center of Reproductive Medicine, the first Affiliated Hospital of Guangxi Medical University, Nanning, China
8 shared publicationsWeili Qin
Center of Reproductive Medicine, the first Affiliated Hospital of Guangxi Medical University, Nanning, China
8 shared publicationsYihua Yang
Reproductive Center, Guangxi Medical University First Affiliated Hospital, Nanning, Guangxi, China
8 shared publications
Latest Publications
- Open Access
- 20 September 2026
- Published by Springer Nature in European Journal of Medical Research
Immune-associated molecular alterations in intrauterine adhesion highlight potential targets for fibrotic endometrial remodeling
- 20 September 2026
- Published by Springer Nature in European Journal of Medical Research
Open AccessImmune-associated molecular alterations in intrauterine adhesion highlight potential targets for fibrotic endometrial remodeling
- Open Access
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9981
An endometrial immune atlas across the female menstrual cycle reveals lymphoid aggregates compromise pregnancy
The human endometrial immune landscape is critical for homeostasis and pregnancy success, yet its dynamic remodeling across the menstrual cycle and in pathology remains poorly characterized. Here, we construct a comprehensive immune cell atlas of the human endometrium, profiling 53 healthy women and 34 chronic endometritis (CE) patients across precisely staged menstrual cycle phases. Our analysis reveals NK and T cells as dominant constituents, with NK cells increasing while T cells decreasing progressively from proliferative to secretory phase. B cells, mast cells, and innate lymphoid cells remain consistently low. Of the two tissue-resident NK subsets, CD11c⁺ NK cells accumulate during the secretory phase and early pregnancy. CE disrupts this landscape, marked by CD11c⁺ NK cell reduction, local B cell proliferation and differentiation, and formation of ectopic lymphoid aggregates comprising germinal-center-B-like cells and T follicular helper-like cells. Using a murine CE model and a subsequent multi-center cohort study we demonstrate that these aggregates compromise pregnancy outcomes in a Tfh-like-cell-dependent manner. Collectively, we establish a detailed immune cell atlas of the cycling human endometrium and define a pathogenic mechanism for adverse pregnancy outcomes.
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9981
Open AccessAn endometrial immune atlas across the female menstrual cycle reveals lymphoid aggregates compromise pregnancy
The human endometrial immune landscape is critical for homeostasis and pregnancy success, yet its dynamic remodeling across the menstrual cycle and in pathology remains poorly characterized. Here, we construct a comprehensive immune cell atlas of the human endometrium, profiling 53 healthy women and 34 chronic endometritis (CE) patients across precisely staged menstrual cycle phases. Our analysis reveals NK and T cells as dominant constituents, with NK cells increasing while T cells decreasing progressively from proliferative to secretory phase. B cells, mast cells, and innate lymphoid cells remain consistently low. Of the two tissue-resident NK subsets, CD11c⁺ NK cells accumulate during the secretory phase and early pregnancy. CE disrupts this landscape, marked by CD11c⁺ NK cell reduction, local B cell proliferation and differentiation, and formation of ectopic lymphoid aggregates comprising germinal-center-B-like cells and T follicular helper-like cells. Using a murine CE model and a subsequent multi-center cohort study we demonstrate that these aggregates compromise pregnancy outcomes in a Tfh-like-cell-dependent manner. Collectively, we establish a detailed immune cell atlas of the cycling human endometrium and define a pathogenic mechanism for adverse pregnancy outcomes.
- Open Access
- 18 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
HBP1 enhances progesterone receptor activity and IGFBP1 expression driving endometrial decidualization
Decidualization of human endometrial stromal cells (HESCs) is one of the critical steps in the establishment of human pregnancy. Nevertheless, little is known about the molecular mechanisms underlying human decidualization. In this study, we identified high-mobility group box transcription factor 1 (HBP1) as a key player in the decidualization of HESCs. Knockdown of HBP1 expression significantly reduced the mRNA and protein expression levels of the decidualization markers insulin-like growth factor-binding protein 1 (IGFBP1) and forkhead box O1 (FOXO1). Although progesterone receptor (PGR) expression did not significantly change, the expression levels of PGR-regulated target molecules decreased. Furthermore, ChIP-Seq and RNA-Seq analyses revealed that HBP1 directly transcriptionally regulates IGFBP1 expression. Additionally, overexpression of HBP1 promoted the enrichment of histone H3K4me3 at the promoter regions of PGR and its target molecules FK506 binding protein 5 (FKBP5), Fos-related antigen 2 (FRA-2/FOSL2), and FK506-binding protein 4 (FKBP4), which indicated that HBP1 enhances PGR transcriptional activity. Clinical specimen analysis further confirmed that the expression of HBP1 and PGR target molecules was significantly downregulated in the endometria of patients with recurrent implantation failure. In conclusion, this study provides evidence that HBP1 plays an important regulatory role in embryo implantation.
- 18 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessHBP1 enhances progesterone receptor activity and IGFBP1 expression driving endometrial decidualization
Decidualization of human endometrial stromal cells (HESCs) is one of the critical steps in the establishment of human pregnancy. Nevertheless, little is known about the molecular mechanisms underlying human decidualization. In this study, we identified high-mobility group box transcription factor 1 (HBP1) as a key player in the decidualization of HESCs. Knockdown of HBP1 expression significantly reduced the mRNA and protein expression levels of the decidualization markers insulin-like growth factor-binding protein 1 (IGFBP1) and forkhead box O1 (FOXO1). Although progesterone receptor (PGR) expression did not significantly change, the expression levels of PGR-regulated target molecules decreased. Furthermore, ChIP-Seq and RNA-Seq analyses revealed that HBP1 directly transcriptionally regulates IGFBP1 expression. Additionally, overexpression of HBP1 promoted the enrichment of histone H3K4me3 at the promoter regions of PGR and its target molecules FK506 binding protein 5 (FKBP5), Fos-related antigen 2 (FRA-2/FOSL2), and FK506-binding protein 4 (FKBP4), which indicated that HBP1 enhances PGR transcriptional activity. Clinical specimen analysis further confirmed that the expression of HBP1 and PGR target molecules was significantly downregulated in the endometria of patients with recurrent implantation failure. In conclusion, this study provides evidence that HBP1 plays an important regulatory role in embryo implantation.
- Open Access
- 22 November 2025
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (6) , 441
In-situ visible-light-crosslinking of mussel-inspired adhesive and anti-inflammatory HMD hydrogel for intrauterine adhesion prevention via paracrine signaling
- 22 November 2025
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (6) , 441
Open AccessIn-situ visible-light-crosslinking of mussel-inspired adhesive and anti-inflammatory HMD hydrogel for intrauterine adhesion prevention via paracrine signaling
- 21 October 2025
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 49 (2) , 377-386
Impact of retrieved oocyte number on IVF outcomes in polycystic ovary syndrome: a retrospective cohort study
Research question Do different numbers of oocytes retrieved from women with polycystic ovary syndrome (PCOS) influence treatment outcomes and pregnancy-related complications? Methods Retrospective cohort study from The First Affiliated Hospital of Guangxi Medical University and The affiliated hospital of Guilin Medical University. The study population comprised 919 PCOS patients and 4086 women with tubal factor infertility who underwent IVF/ICSI in centers between January 2020 and May 2023. The clinical data of different oocyte retrieved groups were retrospectively analyzed, including baseline characteristics, laboratory parameters, and clinic outcomes. Results There were significant differences in age, type of infertility, AFC, FSH, T, LH, and AMH among groups PCOS ≤ 10, PCOS > 10, Tubal ≤ 10, and Tubal > 10 (all P < 0.05). In the same oocyte groups, the age of PCOS was younger than tubal factor infertility (PCOS ≤ 10 vs. Tubal ≤ 10, PCOS > 10 vs. Tubal > 10; all P < 0.05). The miscarriage rate was higher in patients with PCOS than tubal infertility (P < 0.05). The number of oocytes retrieved in PCOS patients was a protective factor for the miscarriage rate of fresh transplant cycles considering age or other potential confounders, adjusted odds ratio (OR) 0.926, 95% confidence interval (CI) 0.867 to 0.989 (P < 0.05). Conclusions This study demonstrated that PCOS patients exhibit reduced reproductive potential and higher miscarriage rate compared to tubal factor infertility cases. However, increased oocyte retrieval numbers served as a protective factor against miscarriage in fresh IVF cycles of PCOS patients. These findings underscored the importance of oocyte yield as a prognostic indicator in women with PCOS infertility management during in vitro fertilization.
- 21 October 2025
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 49 (2) , 377-386
Impact of retrieved oocyte number on IVF outcomes in polycystic ovary syndrome: a retrospective cohort study
Research question Do different numbers of oocytes retrieved from women with polycystic ovary syndrome (PCOS) influence treatment outcomes and pregnancy-related complications? Methods Retrospective cohort study from The First Affiliated Hospital of Guangxi Medical University and The affiliated hospital of Guilin Medical University. The study population comprised 919 PCOS patients and 4086 women with tubal factor infertility who underwent IVF/ICSI in centers between January 2020 and May 2023. The clinical data of different oocyte retrieved groups were retrospectively analyzed, including baseline characteristics, laboratory parameters, and clinic outcomes. Results There were significant differences in age, type of infertility, AFC, FSH, T, LH, and AMH among groups PCOS ≤ 10, PCOS > 10, Tubal ≤ 10, and Tubal > 10 (all P < 0.05). In the same oocyte groups, the age of PCOS was younger than tubal factor infertility (PCOS ≤ 10 vs. Tubal ≤ 10, PCOS > 10 vs. Tubal > 10; all P < 0.05). The miscarriage rate was higher in patients with PCOS than tubal infertility (P < 0.05). The number of oocytes retrieved in PCOS patients was a protective factor for the miscarriage rate of fresh transplant cycles considering age or other potential confounders, adjusted odds ratio (OR) 0.926, 95% confidence interval (CI) 0.867 to 0.989 (P < 0.05). Conclusions This study demonstrated that PCOS patients exhibit reduced reproductive potential and higher miscarriage rate compared to tubal factor infertility cases. However, increased oocyte retrieval numbers served as a protective factor against miscarriage in fresh IVF cycles of PCOS patients. These findings underscored the importance of oocyte yield as a prognostic indicator in women with PCOS infertility management during in vitro fertilization.
- Open Access
- 30 September 2025
- Published by Springer Nature in Reproductive Health
- Vol. 22 (1) , 1-11
Intrauterine infusion of oil-based medium in women with recurrent implantation failure before frozen embryo transfer: a randomized clinical trial
Oil-based contrast medium in hysterosalpingography has been recommended as an approach to improve fertility in recent years. However, this approach has rarely been applied to patients with unknown recurrent implantation failure (RIF). This randomized clinical trial aimed to assess the effects of intrauterine oil-based contrast infusion on frozen embryo transfer (FET) prognosis and pregnancy outcomes among patients with unknown RIF. This multicenter prospective randomized clinical trial was conducted between November 2019 and December 2022. A total of 224 patients with unknown RIF were randomized to the intrauterine oil-based medium infusion group or the control group at a 1:1 ratio. The oil-based contrast group was intrauterine infused with ethiodized poppy seed oil at a dose of 5 ml before FET, and the control group underwent only a standard FET. The primary outcome was the live birth rate (LBR). The secondary outcomes were implantation rate, clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR), and early miscarriage rate. One hundred patients completed intrauterine oil-based medium infusion followed by FET within 120 days. The intention-to-treat analysis demonstrated balanced baseline characteristics between groups. The oil-based medium group exhibited significantly higher CPR (56% vs. 37.4%, rate ratio (RR) 1.498, 95% CI 1.109–2.023, P = 0.007) and implantation rates (median 50% [interquartile range, IQR 0–100%] vs. median 50% [IQR 0–50%], P = 0.010) compared to controls. However, no statistically significant differences were observed in LBR (39% vs. 27.1%, RR 1.439, 95% CI 0.969–2.138, P = 0.069) or OPR (40% vs. 27.1%, RR 1.476, 95% CI 0.997–2.168, P = 0.049), with the latter approaching borderline significance. Subgroup analyses revealed enhanced CPR specifically in RIF patients aged 35–39 years (P = 0.041) and with gonadotropin-releasing hormone agonist (GnRHa) pretreatment hormone replacement therapy (HRT) (GnRHa-HRT) endometrial preparation protocol (P = 0.008). However, no disparities were observed in the LBR and OPR. Within-group comparison of oil-based medium infusion protocols showed that GnRHa-HRT significantly improved reproductive outcomes versus HRT protocols, including LBR (52.2% vs. 26.1%, RR 1.894, 95% CI 1.035–3.466, P = 0.023), CPR (71.7% vs.39.1%, RR 1.983, 95% CI 1.198–3.283, P = 0.002), OPR(P = 0.047), and implantation rate(P = 0.021), which might be attributed to the thickening of the endometrium (P = 0.027). Infusion with an oil-based medium did not increase the LBR in terms of FET prognosis among patients with unknown RIF. However, compared with HRT, an oil-based contrast agent combined with a GnRHa-HRT FET increased the endometrial thickness and the LBR. These findings suggest synergistic effects of dual interventions, proposing a potential personalized strategy for refractory RIF cases. Further large-scale RCTs and deeper mechanism studies are warranted to validate clinical applicability. Trial registration: This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University and registered at the Chinese Clinical Trial Registry Center ( http://www.chictr.org.cn/index.html , no ChiCTR1900024273) on July 4th, 2019.
- 30 September 2025
- Published by Springer Nature in Reproductive Health
- Vol. 22 (1) , 1-11
Open AccessIntrauterine infusion of oil-based medium in women with recurrent implantation failure before frozen embryo transfer: a randomized clinical trial
Oil-based contrast medium in hysterosalpingography has been recommended as an approach to improve fertility in recent years. However, this approach has rarely been applied to patients with unknown recurrent implantation failure (RIF). This randomized clinical trial aimed to assess the effects of intrauterine oil-based contrast infusion on frozen embryo transfer (FET) prognosis and pregnancy outcomes among patients with unknown RIF. This multicenter prospective randomized clinical trial was conducted between November 2019 and December 2022. A total of 224 patients with unknown RIF were randomized to the intrauterine oil-based medium infusion group or the control group at a 1:1 ratio. The oil-based contrast group was intrauterine infused with ethiodized poppy seed oil at a dose of 5 ml before FET, and the control group underwent only a standard FET. The primary outcome was the live birth rate (LBR). The secondary outcomes were implantation rate, clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR), and early miscarriage rate. One hundred patients completed intrauterine oil-based medium infusion followed by FET within 120 days. The intention-to-treat analysis demonstrated balanced baseline characteristics between groups. The oil-based medium group exhibited significantly higher CPR (56% vs. 37.4%, rate ratio (RR) 1.498, 95% CI 1.109–2.023, P = 0.007) and implantation rates (median 50% [interquartile range, IQR 0–100%] vs. median 50% [IQR 0–50%], P = 0.010) compared to controls. However, no statistically significant differences were observed in LBR (39% vs. 27.1%, RR 1.439, 95% CI 0.969–2.138, P = 0.069) or OPR (40% vs. 27.1%, RR 1.476, 95% CI 0.997–2.168, P = 0.049), with the latter approaching borderline significance. Subgroup analyses revealed enhanced CPR specifically in RIF patients aged 35–39 years (P = 0.041) and with gonadotropin-releasing hormone agonist (GnRHa) pretreatment hormone replacement therapy (HRT) (GnRHa-HRT) endometrial preparation protocol (P = 0.008). However, no disparities were observed in the LBR and OPR. Within-group comparison of oil-based medium infusion protocols showed that GnRHa-HRT significantly improved reproductive outcomes versus HRT protocols, including LBR (52.2% vs. 26.1%, RR 1.894, 95% CI 1.035–3.466, P = 0.023), CPR (71.7% vs.39.1%, RR 1.983, 95% CI 1.198–3.283, P = 0.002), OPR(P = 0.047), and implantation rate(P = 0.021), which might be attributed to the thickening of the endometrium (P = 0.027). Infusion with an oil-based medium did not increase the LBR in terms of FET prognosis among patients with unknown RIF. However, compared with HRT, an oil-based contrast agent combined with a GnRHa-HRT FET increased the endometrial thickness and the LBR. These findings suggest synergistic effects of dual interventions, proposing a potential personalized strategy for refractory RIF cases. Further large-scale RCTs and deeper mechanism studies are warranted to validate clinical applicability. Trial registration: This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University and registered at the Chinese Clinical Trial Registry Center ( http://www.chictr.org.cn/index.html , no ChiCTR1900024273) on July 4th, 2019.
- Open Access
- 1 May 2025
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 312 (2) , 505-513
Comparative analysis of hysterosalpingography and hysterosalpingo-contrast sonography for assessing tubal patency in women with endometriosis-related infertility: a propensity score-matched study
Purpose This study aimed to compare the clinical pregnancy rates of hysterosalpingography (HSG) with water-based contrast and hysterosalpingo-contrast sonography (HyCoSy) to investigate their impact on fertility outcomes in women with endometriosis-related infertility. Methods This retrospective study included 296 women with endometriosis-related infertility, aged 18–39, undergoing HSG or HyCoSy at the First Affiliated Hospital of Guangxi Medical University (January 2020–June 2022). Propensity score matching was applied to balance demographic and clinical variables. Clinical pregnancy outcomes were compared between the groups. Results The HSG group showed a higher clinical pregnancy rates compared to the HyCoSy group. Logistic regression demonstrated an odds ratio (OR) of 0.41 (95% CI 0.20–0.82, p < 0.001) for clinical pregnancy in the HyCoSy group compared to HSG. After propensity score matching, the OR was 0.37 (95% CI 0.18–0.75). Similar results were observed across multivariable and IPTW analyses, suggesting that HSG may be associated with better clinical pregnancy outcomes than HyCoSy. Conclusion Hysterosalpingography (HSG) with water-based contrast appears to be associated with higher clinical pregnancy rates compared to HyCoSy in women with endometriosis-related infertility. This suggests that HSG may be a more favorable diagnostic method for optimizing fertility outcomes, though further research is needed to confirm these findings.
- 1 May 2025
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 312 (2) , 505-513
Open AccessComparative analysis of hysterosalpingography and hysterosalpingo-contrast sonography for assessing tubal patency in women with endometriosis-related infertility: a propensity score-matched study
Purpose This study aimed to compare the clinical pregnancy rates of hysterosalpingography (HSG) with water-based contrast and hysterosalpingo-contrast sonography (HyCoSy) to investigate their impact on fertility outcomes in women with endometriosis-related infertility. Methods This retrospective study included 296 women with endometriosis-related infertility, aged 18–39, undergoing HSG or HyCoSy at the First Affiliated Hospital of Guangxi Medical University (January 2020–June 2022). Propensity score matching was applied to balance demographic and clinical variables. Clinical pregnancy outcomes were compared between the groups. Results The HSG group showed a higher clinical pregnancy rates compared to the HyCoSy group. Logistic regression demonstrated an odds ratio (OR) of 0.41 (95% CI 0.20–0.82, p < 0.001) for clinical pregnancy in the HyCoSy group compared to HSG. After propensity score matching, the OR was 0.37 (95% CI 0.18–0.75). Similar results were observed across multivariable and IPTW analyses, suggesting that HSG may be associated with better clinical pregnancy outcomes than HyCoSy. Conclusion Hysterosalpingography (HSG) with water-based contrast appears to be associated with higher clinical pregnancy rates compared to HyCoSy in women with endometriosis-related infertility. This suggests that HSG may be a more favorable diagnostic method for optimizing fertility outcomes, though further research is needed to confirm these findings.
- 30 December 2024
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 38 (1) , e70005
A Positive Relationship Between Caffeine Intake and Endometriosis: A Cross‐Sectional Study of the National Health and Nutrition Examination Survey 1999–2006
Background: Caffeine has been suggested to have a relationship with endometriosis as a widely consumed psychoactive substance, although findings are inconsistent.Objective: This study explored the potential associations and threshold effects between caffeine intake and endometriosis using cross‐sectional data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2006.Methods: The study included 248 women with endometriosis and 2944 without, aged 20–50 years. Caffeine intake was assessed through a 24‐h dietary recall, and endometriosis was identified via self‐report. Logistic regression models were used to investigate the associations between caffeine intake and endometriosis, adjusting for age, race, body mass index, marital status, education, ever pregnant, smoke, drink, hypertension, hyperlipidemia, diabetes, energy, protein, total fat and dietary fibre. The restricted cubic spline (RCS) regression was employed to examine nonlinear relationships and threshold effects.Results: This study found a significant correlation between endometriosis and caffeine intake, with both high and low levels associated with the condition (OR 1.65, 95% CI: 1.12, 2.42, p = 0.011 for high; OR 1.60, 95% CI: 1.05, 2.44, p = 0.028 for low). Their relationship is still significant after adjustment for covariates. This suggests a complex dose–response relationship, confirmed by RCS regression, which revealed a U‐shaped curve. Endometriosis incidence was lowest at 170.25 mg/day caffeine intake.Conclusion: The research suggests that an optimal caffeine intake is 170.25 mg/day, with both higher and lower levels associated with endometriosis. We acknowledge that the cross‐sectional design limits causal inference and that reliance on self‐reported data may introduce bias. Nevertheless, our findings lay the groundwork for future investigations into the dose–response relationship between caffeine intake and endometriosis.
- 30 December 2024
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 38 (1) , e70005
A Positive Relationship Between Caffeine Intake and Endometriosis: A Cross‐Sectional Study of the National Health and Nutrition Examination Survey 1999–2006
Background: Caffeine has been suggested to have a relationship with endometriosis as a widely consumed psychoactive substance, although findings are inconsistent.Objective: This study explored the potential associations and threshold effects between caffeine intake and endometriosis using cross‐sectional data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2006.Methods: The study included 248 women with endometriosis and 2944 without, aged 20–50 years. Caffeine intake was assessed through a 24‐h dietary recall, and endometriosis was identified via self‐report. Logistic regression models were used to investigate the associations between caffeine intake and endometriosis, adjusting for age, race, body mass index, marital status, education, ever pregnant, smoke, drink, hypertension, hyperlipidemia, diabetes, energy, protein, total fat and dietary fibre. The restricted cubic spline (RCS) regression was employed to examine nonlinear relationships and threshold effects.Results: This study found a significant correlation between endometriosis and caffeine intake, with both high and low levels associated with the condition (OR 1.65, 95% CI: 1.12, 2.42, p = 0.011 for high; OR 1.60, 95% CI: 1.05, 2.44, p = 0.028 for low). Their relationship is still significant after adjustment for covariates. This suggests a complex dose–response relationship, confirmed by RCS regression, which revealed a U‐shaped curve. Endometriosis incidence was lowest at 170.25 mg/day caffeine intake.Conclusion: The research suggests that an optimal caffeine intake is 170.25 mg/day, with both higher and lower levels associated with endometriosis. We acknowledge that the cross‐sectional design limits causal inference and that reliance on self‐reported data may introduce bias. Nevertheless, our findings lay the groundwork for future investigations into the dose–response relationship between caffeine intake and endometriosis.
- Open Access
- 27 November 2024
- Published by Springer Nature in BMC Women's Health
- Vol. 24 (1) , 1-15
Prevalence of thyroid autoantibody positivity in women with infertility: a systematic review and meta-analysis
Thyroid autoimmunity (TAI) is associated with infertility and complications during pregnancy. However, the prevalence of thyroid autoantibodies in women with infertility remains unclear due to variability in study designs, sample sizes, and populations. In this meta-analysis, we aimed to assess the prevalence of thyroid autoantibodies in women with infertility compared with that in healthy controls. Systematic searches were conducted across PubMed, Embase, Web of Science, and the Cochrane Library from inception to February 5, 2024. The inclusion criteria were women with infertility and those with autoimmune thyroid antibodies. Studies in which relevant data could not be extracted, randomized control trial reports, studies with non-original or duplicate data, and non-English articles were excluded. The main outcome was prevalence rate. The worldwide pooled prevalence of thyroid autoantibody positivity was 20%. In contrast, a significantly higher TAI prevalence was noted in the population with infertility than in healthy controls (risk ratio [RR] = 1.51). Subgroup analyses indicated that TAI prevalence was higher in patients receiving both assisted reproductive technology (ART) and non-ART treatments than in healthy controls (RR = 1.37 and 3.06, respectively). TAI prevalence was also higher in the recurrent abortion and non-recurrent abortion groups of infertility than in healthy controls (RR = 1.80 and 1.39, respectively). Additionally, a higher TAI prevalence was found in the euthyroid and non-simple euthyroid groups than in the control group (RR = 2.77 and 1.43, respectively). The prevalence was significantly higher in cases of unexplained infertility, endometriosis, ovulation disorders, and fallopian tube factors among women with infertility than among the control group (RR = 1.53, 1.83, 1.42, and 2.00, respectively). Thyroid autoantibodies are more prevalent in patients with infertility than in healthy controls. Given the presence of thyroid autoantibodies, screening patients with infertility is clinically important.
- 27 November 2024
- Published by Springer Nature in BMC Women's Health
- Vol. 24 (1) , 1-15
Open AccessPrevalence of thyroid autoantibody positivity in women with infertility: a systematic review and meta-analysis
Thyroid autoimmunity (TAI) is associated with infertility and complications during pregnancy. However, the prevalence of thyroid autoantibodies in women with infertility remains unclear due to variability in study designs, sample sizes, and populations. In this meta-analysis, we aimed to assess the prevalence of thyroid autoantibodies in women with infertility compared with that in healthy controls. Systematic searches were conducted across PubMed, Embase, Web of Science, and the Cochrane Library from inception to February 5, 2024. The inclusion criteria were women with infertility and those with autoimmune thyroid antibodies. Studies in which relevant data could not be extracted, randomized control trial reports, studies with non-original or duplicate data, and non-English articles were excluded. The main outcome was prevalence rate. The worldwide pooled prevalence of thyroid autoantibody positivity was 20%. In contrast, a significantly higher TAI prevalence was noted in the population with infertility than in healthy controls (risk ratio [RR] = 1.51). Subgroup analyses indicated that TAI prevalence was higher in patients receiving both assisted reproductive technology (ART) and non-ART treatments than in healthy controls (RR = 1.37 and 3.06, respectively). TAI prevalence was also higher in the recurrent abortion and non-recurrent abortion groups of infertility than in healthy controls (RR = 1.80 and 1.39, respectively). Additionally, a higher TAI prevalence was found in the euthyroid and non-simple euthyroid groups than in the control group (RR = 2.77 and 1.43, respectively). The prevalence was significantly higher in cases of unexplained infertility, endometriosis, ovulation disorders, and fallopian tube factors among women with infertility than among the control group (RR = 1.53, 1.83, 1.42, and 2.00, respectively). Thyroid autoantibodies are more prevalent in patients with infertility than in healthy controls. Given the presence of thyroid autoantibodies, screening patients with infertility is clinically important.